<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01443325</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2011-051</org_study_id>
    <nct_id>NCT01443325</nct_id>
  </id_info>
  <brief_title>Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy Pain</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present placebo-controlled cross-over study the researchers intend to investigate
      analgesic and sensory effects of a lidocaine patch in patients with severe persistent
      inguinal post-herniorrhaphy pain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain reduction with lidocaine patch</measure>
    <time_frame>assessed the last three days in each treatment period</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Inguinal Pain</condition>
  <arm_group>
    <arm_group_label>lidocaine patch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine patch</intervention_name>
    <description>1 patch for 12 hours within each 24 hours period</description>
    <arm_group_label>lidocaine patch</arm_group_label>
    <other_name>versatis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males &gt; 18 yrs

          -  ASA (American Society´s of Anesthesiology´s classification) scores I-III, with severe
             Pain for more than six months and with average daily pain intensities (numerical
             rating scale [NRS] 0-10 points) during rest or during movement &gt; 6.

        Exclusion Criteria:

          -  History of an allergic reaction or intolerance to amide local anesthetics or vehicle
             ingredients in the patches

          -  Use of class I antiarrhythmic drugs (e.g., tocainide and mexiletine)

          -  Severe cardiac impairment, e.g., NYHA (New York Heart Association) Class ≥ III

          -  Inflamed or injured skin at the application site

          -  Known severe hepatic disorder (Child-Pugh score &gt; 6)

          -  Known severe renal impairment, (creatinine clearance &lt; 30 mL/min)

          -  Signs of cognitive impairment or known drug or ethanol abuse during the last 2 years.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2011</study_first_submitted>
  <study_first_submitted_qc>September 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2011</study_first_posted>
  <last_update_submitted>June 21, 2012</last_update_submitted>
  <last_update_submitted_qc>June 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Joakim Bischoff</investigator_full_name>
    <investigator_title>Research fellow, MD</investigator_title>
  </responsible_party>
  <keyword>Persistent Postherniorrhaphy inguinal Pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

